Allegra-D 24 Hour approval
This article was originally published in The Tan Sheet
Executive Summary
FDA clears Allegra-D 24 Hour Extended Release Tablets (fexofenadine HCl 180mg/ pseudoephedrine HCl 240mg) Oct. 19. The once-daily oral dose treats "seasonal allergy symptoms with nasal congestion in adults and children 12 years of age and older," FDA says. Aventis submitted the NDA for Allegra-D 24 Hour in December 2003, according to the firm's 1website...